George Papaxoinis

Summary

Affiliation: University of Athens
Country: Greece

Publications

  1. ncbi request reprint Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG)
    George Papaxoinis
    Second Department of Internal Medicine, Athens University, University General Hospital Attikon, Haidari, Greece
    Leuk Lymphoma 47:2140-6. 2006
  2. ncbi request reprint Two cases of complete response after imatinib mesylate treatment of advanced GIST
    George Papaxoinis
    Second Department of Internal Medicine Propaedeutic, University General Hospital, Attikon University of Athens, 1 Rimini Street, Haidari 12462, Athens, Greece
    Anticancer Res 26:4869-72. 2006
  3. ncbi request reprint Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG)
    G Papaxoinis
    Second Department of Internal Medicine, University General Hospital Attikon, University of Athens, Haidari, Greece
    Ann Oncol 19:780-6. 2008
  4. doi request reprint Carboplatin and paclitaxel in metastatic or recurrent cervical cancer
    Dimitrios Pectasides
    2nd Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Athens, Greece
    Int J Gynecol Cancer 19:777-81. 2009
  5. doi request reprint Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution
    Dimitrios Pectasides
    2nd Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Haidari, Athens, Greece
    Gynecol Oncol 110:299-303. 2008
  6. doi request reprint Methotrexate, paclitaxel, ifosfamide, and cisplatin in poor-risk nonseminomatous germ cell tumors
    Dimitrios Pectasides
    Second Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Athens, Greece
    Urol Oncol 28:617-23. 2010
  7. pmc XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis
    Dimitrios Pectasides
    Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, University of Athens School of Medicine, Athens, Greece
    BMC Cancer 12:271. 2012
  8. ncbi request reprint Combination chemotherapy with docetaxel, vinorelbine and estramustine phosphate in metastatic androgen-resistant prostate cancer: a single institution experience
    Dimitrios Pectasides
    Second Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Haidari, Athens, Greece
    Anticancer Res 29:769-75. 2009
  9. doi request reprint Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study
    Dimitrios Pectasides
    Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, University of Athens School of Medicine, Athens, Greece
    Oncol Rep 27:216-24. 2012
  10. doi request reprint Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group
    Helen Gogas
    First Department of Medicine, Laiko General Hospital, Athens, Greece
    Clin Breast Cancer 10:230-7. 2010

Detail Information

Publications12

  1. ncbi request reprint Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG)
    George Papaxoinis
    Second Department of Internal Medicine, Athens University, University General Hospital Attikon, Haidari, Greece
    Leuk Lymphoma 47:2140-6. 2006
    ..0001). The International Prognostic Index (IPI) for patients with aggressive lymphomas was prognostic only for DFS (79% for low-risk patients [IPI score 0 - 1] vs 49% for higher risk groups [IPI score >1] at 3-year, P = 0.0131)...
  2. ncbi request reprint Two cases of complete response after imatinib mesylate treatment of advanced GIST
    George Papaxoinis
    Second Department of Internal Medicine Propaedeutic, University General Hospital, Attikon University of Athens, 1 Rimini Street, Haidari 12462, Athens, Greece
    Anticancer Res 26:4869-72. 2006
    ..Imatinib mesylate has undoubted efficacy in the treatment of advanced gastrointestinal stromal tumors (GISTs), but complete responses have only been reported rarely...
  3. ncbi request reprint Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG)
    G Papaxoinis
    Second Department of Internal Medicine, University General Hospital Attikon, University of Athens, Haidari, Greece
    Ann Oncol 19:780-6. 2008
    ..The aim was to examine characteristics and treatment results of patients with mucosa-associated lymphoid tissue (MALT) non-Hodgkin's lymphomas...
  4. doi request reprint Carboplatin and paclitaxel in metastatic or recurrent cervical cancer
    Dimitrios Pectasides
    2nd Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Athens, Greece
    Int J Gynecol Cancer 19:777-81. 2009
    ..The purpose of this study was to evaluate the activity and toxicity of carboplatin and paclitaxel combination in advanced or recurrent carcinoma of the cervix...
  5. doi request reprint Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution
    Dimitrios Pectasides
    2nd Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Haidari, Athens, Greece
    Gynecol Oncol 110:299-303. 2008
    ..The purpose of this study was to evaluate the activity and toxicity of carboplatin, paclitaxel and pegylated liposomal doxorubicin combination in advanced or recurrent of the uterine carcinosarcoma...
  6. doi request reprint Methotrexate, paclitaxel, ifosfamide, and cisplatin in poor-risk nonseminomatous germ cell tumors
    Dimitrios Pectasides
    Second Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Athens, Greece
    Urol Oncol 28:617-23. 2010
    ..The efficacy and tolerability of M-TIP was evaluated as first-line treatment for patients with poor-risk germ cell tumors (GCT), according to International Germ Cell Cancer Collaborative Group (IGCCCG) criteria...
  7. pmc XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis
    Dimitrios Pectasides
    Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, University of Athens School of Medicine, Athens, Greece
    BMC Cancer 12:271. 2012
    ..The aim was to compare two standard chemotherapy regimens combined with bevacizumab as first-line treatment in patients with metastatic colorectal cancer...
  8. ncbi request reprint Combination chemotherapy with docetaxel, vinorelbine and estramustine phosphate in metastatic androgen-resistant prostate cancer: a single institution experience
    Dimitrios Pectasides
    Second Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Haidari, Athens, Greece
    Anticancer Res 29:769-75. 2009
    ..The aim of this study was to evaluate the activity and toxicity of docetaxel, vinorelbine and oral estramustine in androgen-resistant prostate cancer (ARPC)...
  9. doi request reprint Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study
    Dimitrios Pectasides
    Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, University of Athens School of Medicine, Athens, Greece
    Oncol Rep 27:216-24. 2012
    ....
  10. doi request reprint Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group
    Helen Gogas
    First Department of Medicine, Laiko General Hospital, Athens, Greece
    Clin Breast Cancer 10:230-7. 2010
    ..This phase II study sought to evaluate the efficacy of the paclitaxel-carboplatin combination as neoadjuvant chemotherapy in patients with locally advanced breast cancer (LABC)...
  11. doi request reprint Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications
    Aspasia Soultati
    Department of Medical Oncology and Translational Research, 251 General Airforce Hospital, Athens, Greece
    Cancer Treat Rev 38:473-83. 2012
    ..In the current review we provide a comprehensive overview of the effects of cytotoxic chemotherapeutic agents on endothelial function and the clinical implications of chemotherapy-associated endothelial toxicity in patients with cancer...
  12. ncbi request reprint Gemcitabine and pegylated liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel-pretreated, ovarian carcinoma
    Dimitrios Pectasides
    2nd Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Haidari, 1 Rimini, Athens, Greece
    Gynecol Oncol 108:47-52. 2008
    ....